It not only suppressed inflammatory response states in astrocytes following ischemic stroke by targeting lipocalin 2 (LCN2) but also inhibited the target of caspase-9 and apoptosis-related cysteine peptidase (Casp9) against ischemic stroke (IS) injury. The gene discussed is CASP9; the disease is ischemic stroke.